「Lumakras」熱門搜尋資訊

Lumakras

「Lumakras」文章包含有:「HowDoesLUMAKRAS®work?」、「KRAS抑制劑再增好消息!Lumakras第三期達標!」、「LumakrasDigitalBrochure.pdf」、「LUMAKRAS®(sotorasib)」、「LUMAKRAS®(sotorasib)」、「Once」、「PressReleases」、「《KRAS》安進(Amgen)KRAS抑制劑Lumakras肺癌治療「憂...」、「《KRAS》安進(Amgen)KRAS抑制劑Lumakras治療非小細胞...」、「洛滿舒膜Sotorasib(LUMAKRAS)」

查看更多
Provide From Google
How Does LUMAKRAS® work?
How Does LUMAKRAS® work?

https://www.lumakras.com

LUMAKRAS® is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body or cannot be ...

Provide From Google
KRAS 抑制劑再增好消息!Lumakras 第三期達標!
KRAS 抑制劑再增好消息!Lumakras 第三期達標!

https://geneonline.news

LUMAKRAS 適用於治療罹患KRAS G12C 基因突變至少接受過一次治療的局部晚期或轉移性非小細胞肺癌(NSCLC) 的成年病人。

Provide From Google
LumakrasDigitalBrochure.pdf
LumakrasDigitalBrochure.pdf

https://www.lumakrashcp.com

LUMAKRAS™ is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC):. • that has spread to other parts of the body or cannot be ...

Provide From Google
LUMAKRAS® (sotorasib)
LUMAKRAS® (sotorasib)

https://www.lumakrashcp.com

LUMAKRAS is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as ...

Provide From Google
LUMAKRAS® (sotorasib)
LUMAKRAS® (sotorasib)

https://www.lumakras.com

LUMAKRAS® is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body or cannot be ...

Provide From Google
Once
Once

https://www.lumakrashcp.com

LUMAKRAS is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as ...

Provide From Google
Press Releases
Press Releases

https://www.amgen.com

LUMAKRAS is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer ( ...

Provide From Google
《KRAS》安進(Amgen) KRAS 抑制劑Lumakras 肺癌治療「憂 ...
《KRAS》安進(Amgen) KRAS 抑制劑Lumakras 肺癌治療「憂 ...

http://www.genetinfo.com

八月初,在2022 年世界肺癌會議(WCLC) 上,安進(Amgen) 公布了將其KRAS G12C抑制劑Lumakras (sotorasib) 用於治療肺癌的兩項研究「憂喜參半」的最新 ...

Provide From Google
《KRAS》安進(Amgen)KRAS 抑制劑Lumakras 治療非小細胞 ...
《KRAS》安進(Amgen)KRAS 抑制劑Lumakras 治療非小細胞 ...

http://www.genetinfo.com

安進(Amgen) 公司的KRAS 抑制劑Lumakras,於2021 年5 月透過美國FDA 的加速批准途徑上市,作為治療KRAS G12C 突變的晚期局部或轉移性非小細胞肺癌(NSCLC) ...

Provide From Google
洛滿舒膜Sotorasib (LUMAKRAS)
洛滿舒膜Sotorasib (LUMAKRAS)

https://crc.uptocare.com

Sotorasib 是一種口服標靶藥物(KRAS G12C 的抑制劑)。 其機轉,是抑制具有KRAS G12C 突變的癌細胞。